{"id":12761,"date":"2023-07-03T16:04:48","date_gmt":"2023-07-03T13:04:48","guid":{"rendered":"https:\/\/stage.www.cobalt.legal\/?p=12761"},"modified":"2025-11-06T14:39:36","modified_gmt":"2025-11-06T12:39:36","slug":"cobalt-konsultavo-stada-arzneimittel-siai-isigyjant-walmark","status":"publish","type":"post","link":"https:\/\/www.cobalt.legal\/lt\/news-cases\/cobalt-konsultavo-stada-arzneimittel-siai-isigyjant-walmark\/","title":{"rendered":"COBALT konsultavo \u201cSTADA Arzneimittel\u201d \u0161iai \u012fsigyjant \u201eWalmark\u201c"},"content":{"rendered":"

COBALT, kaip \u201eSTADA Arzneimittel\u201c teisinis patar\u0117jas Baltijos \u0161alyse, atstovavo \u0161iai \u012fmonei \u012fsigyjant Centrin\u0117je Europoje pirmaujan\u010di\u0105 vartotoj\u0173 sveikatos prie\u017ei\u016bros produkt\u0173 gamintoj\u0105 \u201eWalmark\u201c i\u0161 \u201eMid Europa Partners\u201c (sandorio vert\u0117 neatskleid\u017eiama).<\/p>\n

\u201eWalmark\u201c turi 9 filialus Europos S\u0105jungos \u0161alyse, \u012fskaitant \u010cekij\u0105, Slovakij\u0105, Lenkij\u0105, Vengrij\u0105, Bulgarij\u0105, Rumunij\u0105, Estij\u0105, Latvij\u0105 ir Lietuv\u0105, ir prekiauja unikaliais \u012fvairi\u0173 kategorij\u0173 vartotoj\u0173 sveikatos prie\u017ei\u016bros produktais, pa\u017eym\u0117tais \u017einomais preki\u0173 \u017eenklais, daugiau kaip 40-yje \u0161ali\u0173 visame pasaulyje.<\/p>\n

\u201eSTADA\u201c yra pirmaujanti auk\u0161tos kokyb\u0117s vaist\u0173 gamintoja, prekiaujanti savo produkcija ma\u017edaug 120-yje pasaulio \u0161ali\u0173.<\/p>\n

I\u0161 COBALT pus\u0117s projektui vadovavo partneris Martinas Simovartas ir vyresnysis teisininkas Madis Reppo padedant partneriui Elo Tamm, asocijuotai teisininkei Marit Martens ir asocijuotam teisininkui Tiit-Gregor Mets Estijoje, taip pat partneris Guntars Z\u012ble, vyresnieji teisininkai Elina Lo\u010dmele, U\u0123is Zelti\u0146\u0161 ir asocijuota teisininke Di\u0101na Zepa Latvijoje, ir partneriai Dr.\u00a0Juozas Rimas ir Rasa Za\u0161\u010diurinskait\u0117 bei asocijuotos teisinink\u0117s Julija Timo\u0161\u010denko ir Samanta \u0160ereikait\u0117 Lietuvoje.<\/p>\n","protected":false},"excerpt":{"rendered":"

COBALT, kaip \u201eSTADA Arzneimittel\u201c teisinis patar\u0117jas Baltijos \u0161alyse, atstovavo \u0161iai \u012fmonei \u012fsigyjant Centrin\u0117je Europoje pirmaujan\u010di\u0105 vartotoj\u0173 sveikatos prie\u017ei\u016bros produkt\u0173 gamintoj\u0105 \u201eWalmark\u201c i\u0161 \u201eMid Europa Partners\u201c (sandorio vert\u0117 neatskleid\u017eiama). \u201eWalmark\u201c turi 9 filialus Europos S\u0105jungos \u0161alyse, \u012fskaitant \u010cekij\u0105, Slovakij\u0105, Lenkij\u0105, Vengrij\u0105,..<\/p>\n","protected":false},"author":5,"featured_media":45096,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"categories":[29],"country":[99,97,92],"class_list":["post-12761","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized-lt","country-estonia-lt","country-latvia-lt","country-lithuania-lt"],"acf":[],"yoast_head":"\nCOBALT konsultavo \u201cSTADA Arzneimittel\u201d \u0161iai \u012fsigyjant \u201eWalmark\u201c | COBALT<\/title>\n<meta name=\"description\" content=\"COBALT konsultavo \u201cSTADA Arzneimittel\u201d \u0161iai \u012fsigyjant \u201eWalmark\u201c. News. Naujienos. Jaunumi. Uudised.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.cobalt.legal\/lt\/news-cases\/cobalt-konsultavo-stada-arzneimittel-siai-isigyjant-walmark\/\" \/>\n<meta property=\"og:locale\" content=\"lt_LT\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"COBALT konsultavo \u201cSTADA Arzneimittel\u201d \u0161iai \u012fsigyjant \u201eWalmark\u201c | COBALT\" \/>\n<meta property=\"og:description\" content=\"COBALT konsultavo \u201cSTADA Arzneimittel\u201d \u0161iai \u012fsigyjant \u201eWalmark\u201c. News. Naujienos. Jaunumi. Uudised.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.cobalt.legal\/lt\/news-cases\/cobalt-konsultavo-stada-arzneimittel-siai-isigyjant-walmark\/\" \/>\n<meta property=\"og:site_name\" content=\"COBALT\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/CobaltLegal\/\" \/>\n<meta property=\"article:published_time\" content=\"2023-07-03T13:04:48+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-11-06T12:39:36+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.cobalt.legal\/wp-content\/uploads\/2023\/07\/officebuilding-6.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2765\" \/>\n\t<meta property=\"og:image:height\" content=\"2332\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"saturs\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"saturs\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minut\u0117\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.cobalt.legal\\\/lt\\\/news-cases\\\/cobalt-konsultavo-stada-arzneimittel-siai-isigyjant-walmark\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.cobalt.legal\\\/lt\\\/news-cases\\\/cobalt-konsultavo-stada-arzneimittel-siai-isigyjant-walmark\\\/\"},\"author\":{\"name\":\"saturs\",\"@id\":\"https:\\\/\\\/www.cobalt.legal\\\/lt\\\/#\\\/schema\\\/person\\\/8b9371cd6186321c5b42e891663a4ec0\"},\"headline\":\"COBALT konsultavo \u201cSTADA Arzneimittel\u201d \u0161iai \u012fsigyjant \u201eWalmark\u201c\",\"datePublished\":\"2023-07-03T13:04:48+00:00\",\"dateModified\":\"2025-11-06T12:39:36+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.cobalt.legal\\\/lt\\\/news-cases\\\/cobalt-konsultavo-stada-arzneimittel-siai-isigyjant-walmark\\\/\"},\"wordCount\":168,\"publisher\":{\"@id\":\"https:\\\/\\\/www.cobalt.legal\\\/lt\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.cobalt.legal\\\/lt\\\/news-cases\\\/cobalt-konsultavo-stada-arzneimittel-siai-isigyjant-walmark\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.cobalt.legal\\\/wp-content\\\/uploads\\\/2023\\\/07\\\/officebuilding-6.jpg\",\"articleSection\":[\"Uncategorized @lt\"],\"inLanguage\":\"lt-LT\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.cobalt.legal\\\/lt\\\/news-cases\\\/cobalt-konsultavo-stada-arzneimittel-siai-isigyjant-walmark\\\/\",\"url\":\"https:\\\/\\\/www.cobalt.legal\\\/lt\\\/news-cases\\\/cobalt-konsultavo-stada-arzneimittel-siai-isigyjant-walmark\\\/\",\"name\":\"COBALT konsultavo \u201cSTADA Arzneimittel\u201d \u0161iai \u012fsigyjant \u201eWalmark\u201c | COBALT\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.cobalt.legal\\\/lt\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.cobalt.legal\\\/lt\\\/news-cases\\\/cobalt-konsultavo-stada-arzneimittel-siai-isigyjant-walmark\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.cobalt.legal\\\/lt\\\/news-cases\\\/cobalt-konsultavo-stada-arzneimittel-siai-isigyjant-walmark\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.cobalt.legal\\\/wp-content\\\/uploads\\\/2023\\\/07\\\/officebuilding-6.jpg\",\"datePublished\":\"2023-07-03T13:04:48+00:00\",\"dateModified\":\"2025-11-06T12:39:36+00:00\",\"description\":\"COBALT konsultavo \u201cSTADA Arzneimittel\u201d \u0161iai \u012fsigyjant \u201eWalmark\u201c. News. Naujienos. Jaunumi. Uudised.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.cobalt.legal\\\/lt\\\/news-cases\\\/cobalt-konsultavo-stada-arzneimittel-siai-isigyjant-walmark\\\/#breadcrumb\"},\"inLanguage\":\"lt-LT\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.cobalt.legal\\\/lt\\\/news-cases\\\/cobalt-konsultavo-stada-arzneimittel-siai-isigyjant-walmark\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"lt-LT\",\"@id\":\"https:\\\/\\\/www.cobalt.legal\\\/lt\\\/news-cases\\\/cobalt-konsultavo-stada-arzneimittel-siai-isigyjant-walmark\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.cobalt.legal\\\/wp-content\\\/uploads\\\/2023\\\/07\\\/officebuilding-6.jpg\",\"contentUrl\":\"https:\\\/\\\/www.cobalt.legal\\\/wp-content\\\/uploads\\\/2023\\\/07\\\/officebuilding-6.jpg\",\"width\":2765,\"height\":2332},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.cobalt.legal\\\/lt\\\/news-cases\\\/cobalt-konsultavo-stada-arzneimittel-siai-isigyjant-walmark\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.cobalt.legal\\\/lt\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"COBALT konsultavo \u201cSTADA Arzneimittel\u201d \u0161iai \u012fsigyjant \u201eWalmark\u201c\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.cobalt.legal\\\/lt\\\/#website\",\"url\":\"https:\\\/\\\/www.cobalt.legal\\\/lt\\\/\",\"name\":\"COBALT\",\"description\":\"Top-tier law services in Estonia, Latvia and Lithuania\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.cobalt.legal\\\/lt\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.cobalt.legal\\\/lt\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"lt-LT\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.cobalt.legal\\\/lt\\\/#organization\",\"name\":\"COBALT\",\"url\":\"https:\\\/\\\/www.cobalt.legal\\\/lt\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"lt-LT\",\"@id\":\"https:\\\/\\\/www.cobalt.legal\\\/lt\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.cobalt.legal\\\/wp-content\\\/uploads\\\/2023\\\/04\\\/cobalt-logo.png\",\"contentUrl\":\"https:\\\/\\\/www.cobalt.legal\\\/wp-content\\\/uploads\\\/2023\\\/04\\\/cobalt-logo.png\",\"width\":400,\"height\":116,\"caption\":\"COBALT\"},\"image\":{\"@id\":\"https:\\\/\\\/www.cobalt.legal\\\/lt\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/CobaltLegal\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.cobalt.legal\\\/lt\\\/#\\\/schema\\\/person\\\/8b9371cd6186321c5b42e891663a4ec0\",\"name\":\"saturs\",\"url\":\"https:\\\/\\\/www.cobalt.legal\\\/lt\\\/author\\\/saturs\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"COBALT konsultavo \u201cSTADA Arzneimittel\u201d \u0161iai \u012fsigyjant \u201eWalmark\u201c | COBALT","description":"COBALT konsultavo \u201cSTADA Arzneimittel\u201d \u0161iai \u012fsigyjant \u201eWalmark\u201c. News. Naujienos. Jaunumi. Uudised.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.cobalt.legal\/lt\/news-cases\/cobalt-konsultavo-stada-arzneimittel-siai-isigyjant-walmark\/","og_locale":"lt_LT","og_type":"article","og_title":"COBALT konsultavo \u201cSTADA Arzneimittel\u201d \u0161iai \u012fsigyjant \u201eWalmark\u201c | COBALT","og_description":"COBALT konsultavo \u201cSTADA Arzneimittel\u201d \u0161iai \u012fsigyjant \u201eWalmark\u201c. News. Naujienos. Jaunumi. Uudised.","og_url":"https:\/\/www.cobalt.legal\/lt\/news-cases\/cobalt-konsultavo-stada-arzneimittel-siai-isigyjant-walmark\/","og_site_name":"COBALT","article_publisher":"https:\/\/www.facebook.com\/CobaltLegal\/","article_published_time":"2023-07-03T13:04:48+00:00","article_modified_time":"2025-11-06T12:39:36+00:00","og_image":[{"width":2765,"height":2332,"url":"https:\/\/www.cobalt.legal\/wp-content\/uploads\/2023\/07\/officebuilding-6.jpg","type":"image\/jpeg"}],"author":"saturs","twitter_card":"summary_large_image","twitter_misc":{"Written by":"saturs","Est. reading time":"1 minut\u0117"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.cobalt.legal\/lt\/news-cases\/cobalt-konsultavo-stada-arzneimittel-siai-isigyjant-walmark\/#article","isPartOf":{"@id":"https:\/\/www.cobalt.legal\/lt\/news-cases\/cobalt-konsultavo-stada-arzneimittel-siai-isigyjant-walmark\/"},"author":{"name":"saturs","@id":"https:\/\/www.cobalt.legal\/lt\/#\/schema\/person\/8b9371cd6186321c5b42e891663a4ec0"},"headline":"COBALT konsultavo \u201cSTADA Arzneimittel\u201d \u0161iai \u012fsigyjant \u201eWalmark\u201c","datePublished":"2023-07-03T13:04:48+00:00","dateModified":"2025-11-06T12:39:36+00:00","mainEntityOfPage":{"@id":"https:\/\/www.cobalt.legal\/lt\/news-cases\/cobalt-konsultavo-stada-arzneimittel-siai-isigyjant-walmark\/"},"wordCount":168,"publisher":{"@id":"https:\/\/www.cobalt.legal\/lt\/#organization"},"image":{"@id":"https:\/\/www.cobalt.legal\/lt\/news-cases\/cobalt-konsultavo-stada-arzneimittel-siai-isigyjant-walmark\/#primaryimage"},"thumbnailUrl":"https:\/\/www.cobalt.legal\/wp-content\/uploads\/2023\/07\/officebuilding-6.jpg","articleSection":["Uncategorized @lt"],"inLanguage":"lt-LT"},{"@type":"WebPage","@id":"https:\/\/www.cobalt.legal\/lt\/news-cases\/cobalt-konsultavo-stada-arzneimittel-siai-isigyjant-walmark\/","url":"https:\/\/www.cobalt.legal\/lt\/news-cases\/cobalt-konsultavo-stada-arzneimittel-siai-isigyjant-walmark\/","name":"COBALT konsultavo \u201cSTADA Arzneimittel\u201d \u0161iai \u012fsigyjant \u201eWalmark\u201c | COBALT","isPartOf":{"@id":"https:\/\/www.cobalt.legal\/lt\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.cobalt.legal\/lt\/news-cases\/cobalt-konsultavo-stada-arzneimittel-siai-isigyjant-walmark\/#primaryimage"},"image":{"@id":"https:\/\/www.cobalt.legal\/lt\/news-cases\/cobalt-konsultavo-stada-arzneimittel-siai-isigyjant-walmark\/#primaryimage"},"thumbnailUrl":"https:\/\/www.cobalt.legal\/wp-content\/uploads\/2023\/07\/officebuilding-6.jpg","datePublished":"2023-07-03T13:04:48+00:00","dateModified":"2025-11-06T12:39:36+00:00","description":"COBALT konsultavo \u201cSTADA Arzneimittel\u201d \u0161iai \u012fsigyjant \u201eWalmark\u201c. News. Naujienos. Jaunumi. Uudised.","breadcrumb":{"@id":"https:\/\/www.cobalt.legal\/lt\/news-cases\/cobalt-konsultavo-stada-arzneimittel-siai-isigyjant-walmark\/#breadcrumb"},"inLanguage":"lt-LT","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.cobalt.legal\/lt\/news-cases\/cobalt-konsultavo-stada-arzneimittel-siai-isigyjant-walmark\/"]}]},{"@type":"ImageObject","inLanguage":"lt-LT","@id":"https:\/\/www.cobalt.legal\/lt\/news-cases\/cobalt-konsultavo-stada-arzneimittel-siai-isigyjant-walmark\/#primaryimage","url":"https:\/\/www.cobalt.legal\/wp-content\/uploads\/2023\/07\/officebuilding-6.jpg","contentUrl":"https:\/\/www.cobalt.legal\/wp-content\/uploads\/2023\/07\/officebuilding-6.jpg","width":2765,"height":2332},{"@type":"BreadcrumbList","@id":"https:\/\/www.cobalt.legal\/lt\/news-cases\/cobalt-konsultavo-stada-arzneimittel-siai-isigyjant-walmark\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.cobalt.legal\/lt\/"},{"@type":"ListItem","position":2,"name":"COBALT konsultavo \u201cSTADA Arzneimittel\u201d \u0161iai \u012fsigyjant \u201eWalmark\u201c"}]},{"@type":"WebSite","@id":"https:\/\/www.cobalt.legal\/lt\/#website","url":"https:\/\/www.cobalt.legal\/lt\/","name":"COBALT","description":"Top-tier law services in Estonia, Latvia and Lithuania","publisher":{"@id":"https:\/\/www.cobalt.legal\/lt\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cobalt.legal\/lt\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"lt-LT"},{"@type":"Organization","@id":"https:\/\/www.cobalt.legal\/lt\/#organization","name":"COBALT","url":"https:\/\/www.cobalt.legal\/lt\/","logo":{"@type":"ImageObject","inLanguage":"lt-LT","@id":"https:\/\/www.cobalt.legal\/lt\/#\/schema\/logo\/image\/","url":"https:\/\/www.cobalt.legal\/wp-content\/uploads\/2023\/04\/cobalt-logo.png","contentUrl":"https:\/\/www.cobalt.legal\/wp-content\/uploads\/2023\/04\/cobalt-logo.png","width":400,"height":116,"caption":"COBALT"},"image":{"@id":"https:\/\/www.cobalt.legal\/lt\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/CobaltLegal\/"]},{"@type":"Person","@id":"https:\/\/www.cobalt.legal\/lt\/#\/schema\/person\/8b9371cd6186321c5b42e891663a4ec0","name":"saturs","url":"https:\/\/www.cobalt.legal\/lt\/author\/saturs\/"}]}},"_links":{"self":[{"href":"https:\/\/www.cobalt.legal\/lt\/wp-json\/wp\/v2\/posts\/12761","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cobalt.legal\/lt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.cobalt.legal\/lt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.cobalt.legal\/lt\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cobalt.legal\/lt\/wp-json\/wp\/v2\/comments?post=12761"}],"version-history":[{"count":2,"href":"https:\/\/www.cobalt.legal\/lt\/wp-json\/wp\/v2\/posts\/12761\/revisions"}],"predecessor-version":[{"id":49590,"href":"https:\/\/www.cobalt.legal\/lt\/wp-json\/wp\/v2\/posts\/12761\/revisions\/49590"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cobalt.legal\/lt\/wp-json\/wp\/v2\/media\/45096"}],"wp:attachment":[{"href":"https:\/\/www.cobalt.legal\/lt\/wp-json\/wp\/v2\/media?parent=12761"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.cobalt.legal\/lt\/wp-json\/wp\/v2\/categories?post=12761"},{"taxonomy":"country","embeddable":true,"href":"https:\/\/www.cobalt.legal\/lt\/wp-json\/wp\/v2\/country?post=12761"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}